Release 4B 5

This page is part of the FHIR Specification (v4.3.0: R4B (v5.0.0: R5 - STU ). The This is the current published version which supercedes in it's permanent home (it will always be available at this version is 5.0.0 . URL). For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R5 R4B R4

Financial Management icon Work Group Maturity Level : 2 4   Trial Use Compartments : Patient , RelatedPerson

Dependency Graph for Coverage FMM level 2 4

Name Card. Type Dependency Analysis
. . Coverage DomainResource
. . . identifier 0..* Identifier
. . . status 1..1 code
. . . kind 1..1 code
.... party 1..1 Reference ( Patient | RelatedPerson | Organization )
.... responsibility 0..1 string
. . . type 0..1 CodeableConcept
. . . policyHolder 0..1 Reference ( Patient | RelatedPerson | Organization )
. . . subscriber 0..1 Reference ( Patient | RelatedPerson )
. . . subscriberId 0..1 0..* string Identifier
. . . beneficiary 1..1 Reference ( Patient )
. . . dependent 0..1 string
. . . relationship 0..1 CodeableConcept
. . . period 0..1 Period
. . . payor insurer 1..* 0..1 Reference ( Organization | Patient | RelatedPerson )
. . . class 0..* BackboneElement
. . . . type 1..1 CodeableConcept
. . . . value 1..1 string Identifier
. . . . name 0..1 string
. . . order 0..1 positiveInt
. . . network 0..1 string
. . . costToBeneficiary 0..* BackboneElement
. . . . type 0..1 CodeableConcept
. . . . category 0..1 CodeableConcept
.... network 0..1 CodeableConcept
.... unit 0..1 CodeableConcept
. . . . term 0..1 CodeableConcept
. . . . value[x] 1..1 0..1
. . . . . valueQuantity SimpleQuantity
. . . . . valueMoney Money
. . . . exception 0..* BackboneElement
. . . . . type 1..1 CodeableConcept
. . . . . period 0..1 Period
. . . subrogation 0..1 boolean
. . . contract 0..* Reference ( Contract ) Type Warning: (Contract = FMM1-Trial Use vs. Element = FMM2-Trial FMM4-Trial Use)
... insurancePlan 0..1 Reference ( InsurancePlan ) Type Warning: (InsurancePlan = FMM0-Trial Use vs. Element = FMM4-Trial Use)